Suppr超能文献

蛋白S部分缺乏患者的复发性静脉血栓栓塞症

Recurrent venous thromboembolism in patients with a partial deficiency of protein S.

作者信息

Comp P C, Esmon C T

出版信息

N Engl J Med. 1984 Dec 13;311(24):1525-8. doi: 10.1056/NEJM198412133112401.

Abstract

Protein S is an antithrombotic plasma protein that serves as a cofactor for another plasma protein, activated protein C. Protein S is required for the expression of the anticoagulant effect of activated protein C, which inhibits blood clotting at the levels of factors V and VIII in the blood-clotting cascade. We postulated that patients deficient in protein S would have inadequate regulatory control of the clotting cascade and would be prone to thrombotic disease in a manner similar to that of patients congenitally deficient in protein C. To determine whether protein S deficiency is associated with recurrent thrombosis, we developed a functional assay for the plasma protein. With this assay, the protein S activity of normal persons ranges from 63 to 160 per cent. Using this test, we have now identified six unrelated persons with severe recurrent venous thrombosis who were deficient in protein S, with levels between 15 and 37 per cent while they were not receiving warfarin therapy. Our data suggest that the determination of protein S levels will be useful in the evaluation of patients with recurrent thrombosis.

摘要

蛋白S是一种抗血栓形成的血浆蛋白,作为另一种血浆蛋白——活化蛋白C的辅因子。活化蛋白C发挥抗凝作用需要蛋白S参与,活化蛋白C在凝血级联反应中通过抑制因子V和VIII来抑制血液凝固。我们推测,蛋白S缺乏的患者对凝血级联反应的调节控制不足,并且会像先天性蛋白C缺乏的患者一样容易患血栓形成性疾病。为了确定蛋白S缺乏是否与复发性血栓形成有关,我们开发了一种针对该血浆蛋白的功能测定方法。通过这种测定方法,正常人的蛋白S活性范围为63%至160%。使用该测试,我们现已确定6名患有严重复发性静脉血栓形成的无血缘关系个体,他们在未接受华法林治疗时蛋白S缺乏,水平在15%至37%之间。我们的数据表明,测定蛋白S水平将有助于评估复发性血栓形成的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验